BNP Paribas Financial Markets’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $291K | Sell |
|
|||||
|
2025
Q1 | $446K | Sell |
|
|||||
|
2024
Q4 | $488K | Sell |
|
|||||
|
2024
Q3 | $2.61M | Sell |
|
|||||
|
2024
Q2 | $6.3M | Sell |
|
|||||
|
2024
Q1 | $9.81M | Buy |
|
|||||
|
2023
Q4 | $4.51M | Buy |
|
|||||
|
2023
Q3 | $1.49M | Sell |
|
|||||
|
2023
Q2 | $2.26M | Sell |
|
|||||
|
2023
Q1 | $3.51M | Buy |
|
|||||
|
2022
Q4 | $1.51M | Buy |
|
|||||
|
2022
Q3 | $962K | Buy |
|
|||||
|
2022
Q2 | $696K | Buy |
|
|||||
|
2022
Q1 | $248K | Sell |
|
|||||
|
2021
Q4 | $293K | Sell |
|
|||||
|
2021
Q3 | $673K | Buy |
|
|||||
|
2021
Q2 | $290K | Buy |
|
|||||
|
2021
Q1 | $157K | Sell |
|
|||||
|
2020
Q4 | $141K | Sell |
|
|||||
|
2020
Q3 | $164K | Buy |
|
|||||
|
2020
Q2 | $21.6K | Sell |
|
|||||
|
2020
Q1 | $163K | Buy |
|
|||||
|
2019
Q4 | $78.3K | Sell |
|
|||||
|
2019
Q3 | $55.1K | Buy |
|
|||||
|
2019
Q2 | $43.2K | Sell |
|
|||||
|
2019
Q1 | $92.6K | Buy |
|
|||||
|
2018
Q4 | $155 | Sell |
|
|||||
|
2018
Q3 | $14.2K | Sell |
|
|||||
|
2018
Q2 | $30.1K | Sell |
|
|||||
|
2018
Q1 | $136K | Sell |
|
|||||
|
2017
Q4 | $104K | Buy |
|
|||||
|
2017
Q3 | $21.8K | Sell |
|
|||||
|
2017
Q2 | $27.4K | Buy |
|
|||||
|
2017
Q1 | $241 | Sell |
|
|||||
|
2016
Q4 | $13.5K | Sell |
|
|||||
|
2016
Q3 | $17.6K | Buy |
|
|||||
|
2016
Q2 | $6.28K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $38.4K | Buy |
|
|||||
|
2015
Q3 | $30.5K | Buy |
|